| UniProt ID | CPNE9_HUMAN | |
|---|---|---|
| UniProt AC | Q8IYJ1 | |
| Protein Name | Copine-9 {ECO:0000305} | |
| Gene Name | CPNE9 {ECO:0000312|HGNC:HGNC:24336} | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 553 | |
| Subcellular Localization | ||
| Protein Description | Probable calcium-dependent phospholipid-binding protein that may play a role in calcium-mediated intracellular processes (By similarity). Plays a role in dendrite formation by melanocytes. [PubMed: 23999003] | |
| Protein Sequence | MSLGGASERSVPATKIEITVSCRNLLDLDTFSKSDPMVVLYTQSRASQEWREFGRTEVIDNTLNPDFVRKFVLDYFFEEKQNLRFDVYNVDSKTNISKPKDFLGQAFLALGEVIGGQGSRVERTLTGVPGKKCGTILLTAEELSNCRDIATMQLCANKLDKKDFFGKSDPFLVFYRSNEDGTFTICHKTEVVKNTLNPVWQPFSIPVRALCNGDYDRTVKIDVYDWDRDGSHDFIGEFTTSYRELSKAQNQFTVYEVLNPRKKCKKKKYVNSGTVTLLSFSVDSEFTFVDYIKGGTQLNFTVAIDFTASNGNPLQPTSLHYMSPYQLSAYAMALKAVGEIIQDYDSDKLFPAYGFGAKLPPEGRISHQFPLNNNDEDPNCAGIEGVLESYFQSLRTVQLYGPTYFAPVINQVARAAAKISDGSQYYVLLIITDGVISDMTQTKEAIVSASSLPMSIIIVGVGPAMFEAMEELDGDDVRVSSRGRYAERDIVQFVPFRDYVDRSGNQVLSMARLAKDVLAEIPEQLLSYMRTRDIQPRPPPPANPSPIPAPEQP | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Phosphorylation | ------MSLGGASER ------CCCCCCCCC | 35.40 | 23403867 | |
| 7 | Phosphorylation | -MSLGGASERSVPAT -CCCCCCCCCCCCCC | 36.50 | 23403867 | |
| 10 | Phosphorylation | LGGASERSVPATKIE CCCCCCCCCCCCEEE | 28.53 | 23403867 | |
| 14 | Phosphorylation | SERSVPATKIEITVS CCCCCCCCEEEEEEE | 26.87 | 23403867 | |
| 30 | Phosphorylation | RNLLDLDTFSKSDPM CCCCCCCCCCCCCCE | 36.79 | 23663014 | |
| 32 | Phosphorylation | LLDLDTFSKSDPMVV CCCCCCCCCCCCEEE | 33.08 | 23663014 | |
| 34 | Phosphorylation | DLDTFSKSDPMVVLY CCCCCCCCCCEEEEE | 45.83 | 23663014 | |
| 41 | Phosphorylation | SDPMVVLYTQSRASQ CCCEEEEEECCCCCH | 7.36 | 23663014 | |
| 42 | Phosphorylation | DPMVVLYTQSRASQE CCEEEEEECCCCCHH | 18.86 | 23663014 | |
| 44 | Phosphorylation | MVVLYTQSRASQEWR EEEEEECCCCCHHHH | 23.24 | 23663014 | |
| 62 | Phosphorylation | RTEVIDNTLNPDFVR CCEEECCCCCHHHHH | 24.94 | 21815630 | |
| 95 | N-linked_Glycosylation | YNVDSKTNISKPKDF EECCCCCCCCCCHHH | 40.03 | 16335952 | |
| 132 | Acetylation | LTGVPGKKCGTILLT ECCCCCCCCCEEEEE | 43.76 | 20167786 | |
| 135 | Phosphorylation | VPGKKCGTILLTAEE CCCCCCCEEEEEHHH | 20.23 | 20860994 | |
| 158 | Acetylation | TMQLCANKLDKKDFF HHHHHHHCCCCCHHC | 39.27 | 20167786 | |
| 161 | Acetylation | LCANKLDKKDFFGKS HHHHCCCCCHHCCCC | 65.76 | 20167786 | |
| 161 | Ubiquitination | LCANKLDKKDFFGKS HHHHCCCCCHHCCCC | 65.76 | 23000965 | |
| 162 | Ubiquitination | CANKLDKKDFFGKSD HHHCCCCCHHCCCCC | 60.48 | 23000965 | |
| 167 | Ubiquitination | DKKDFFGKSDPFLVF CCCHHCCCCCCEEEE | 46.67 | 23000965 | |
| 204 | Phosphorylation | NPVWQPFSIPVRALC CCCCCCCCCCHHHHC | 32.44 | 26356563 | |
| 218 | Phosphorylation | CNGDYDRTVKIDVYD CCCCCCCEEEEEEEE | 24.21 | 26074081 | |
| 224 | Phosphorylation | RTVKIDVYDWDRDGS CEEEEEEEECCCCCC | 13.94 | 26074081 | |
| 231 | Phosphorylation | YDWDRDGSHDFIGEF EECCCCCCCCCCEEE | 24.95 | 26074081 | |
| 239 | Phosphorylation | HDFIGEFTTSYRELS CCCCEEEECCHHHHH | 15.55 | 26074081 | |
| 240 | Phosphorylation | DFIGEFTTSYRELSK CCCEEEECCHHHHHH | 29.14 | 26074081 | |
| 241 | Phosphorylation | FIGEFTTSYRELSKA CCEEEECCHHHHHHH | 21.09 | 26074081 | |
| 242 | Phosphorylation | IGEFTTSYRELSKAQ CEEEECCHHHHHHHH | 13.15 | 26074081 | |
| 253 | O-linked_Glycosylation | SKAQNQFTVYEVLNP HHHHHCEEHHHCCCC | 16.65 | 29237092 | |
| 269 | Phosphorylation | KKCKKKKYVNSGTVT HHCCCCCEECCCEEE | 17.47 | 25262027 | |
| 270 | Ubiquitination | KCKKKKYVNSGTVTL HCCCCCEECCCEEEE | 6.71 | 23000965 | |
| 271 | Ubiquitination | CKKKKYVNSGTVTLL CCCCCEECCCEEEEE | 31.47 | 23000965 | |
| 272 | Phosphorylation | KKKKYVNSGTVTLLS CCCCEECCCEEEEEE | 26.29 | 25262027 | |
| 274 | Phosphorylation | KKYVNSGTVTLLSFS CCEECCCEEEEEEEE | 15.33 | 25262027 | |
| 276 | Ubiquitination | YVNSGTVTLLSFSVD EECCCEEEEEEEEEC | 23.09 | 23000965 | |
| 276 | Phosphorylation | YVNSGTVTLLSFSVD EECCCEEEEEEEEEC | 23.09 | 25262027 | |
| 279 | Phosphorylation | SGTVTLLSFSVDSEF CCEEEEEEEEECCCE | 20.70 | 25262027 | |
| 281 | Phosphorylation | TVTLLSFSVDSEFTF EEEEEEEEECCCEEE | 22.95 | 25262027 | |
| 284 | Phosphorylation | LLSFSVDSEFTFVDY EEEEEECCCEEEEEE | 32.24 | 25262027 | |
| 287 | Phosphorylation | FSVDSEFTFVDYIKG EEECCCEEEEEEECC | 20.78 | 25262027 | |
| 291 | Phosphorylation | SEFTFVDYIKGGTQL CCEEEEEEECCCCEE | 10.14 | 25262027 | |
| 393 | Phosphorylation | VLESYFQSLRTVQLY HHHHHHHHHCCEEEC | 15.21 | 24719451 | |
| 499 | Phosphorylation | QFVPFRDYVDRSGNQ EEEEHHHHCCCCCCH | 10.45 | 22210691 | |
| 503 | Phosphorylation | FRDYVDRSGNQVLSM HHHHCCCCCCHHHHH | 37.32 | 22210691 | |
| 509 | Phosphorylation | RSGNQVLSMARLAKD CCCCHHHHHHHHHHH | 16.13 | 22210691 | |
| 527 | Phosphorylation | EIPEQLLSYMRTRDI HCHHHHHHHHHCCCC | 26.02 | 20068231 | |
| 528 | Phosphorylation | IPEQLLSYMRTRDIQ CHHHHHHHHHCCCCC | 7.21 | 20068231 | |
| 545 | Phosphorylation | PPPPANPSPIPAPEQ CCCCCCCCCCCCCCC | 34.96 | 32142685 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CPNE9_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CPNE9_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CPNE9_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
Oops, there are no PPI records of CPNE9_HUMAN !! | ||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| N-linked Glycosylation | |
| Reference | PubMed |
| "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry."; Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.; J. Proteome Res. 4:2070-2080(2005). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-95, AND MASS SPECTROMETRY. | |